Oncology Today with Dr Neil Love

348 Jaksot

1. Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer

   Julkaistiin: 20.5.2024
2. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia

   Julkaistiin: 13.5.2024
3. Virtual Case Library: Metastatic Triple-Negative Breast Cancer

   Julkaistiin: 8.5.2024
4. Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition

   Julkaistiin: 6.5.2024
5. Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer

   Julkaistiin: 3.5.2024
6. Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series

   Julkaistiin: 1.5.2024
7. Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria

   Julkaistiin: 26.4.2024
8. Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium

   Julkaistiin: 24.4.2024
9. Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences

   Julkaistiin: 23.4.2024
10. Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition

    Julkaistiin: 15.4.2024
11. Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences

    Julkaistiin: 12.4.2024
12. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer

    Julkaistiin: 5.4.2024
13. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer

    Julkaistiin: 5.4.2024
14. The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates

    Julkaistiin: 3.4.2024
15. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer

    Julkaistiin: 27.3.2024
16. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma

    Julkaistiin: 26.3.2024
17. Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer

    Julkaistiin: 25.3.2024
18. Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review

    Julkaistiin: 21.3.2024
19. Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer

    Julkaistiin: 19.3.2024
20. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer

    Julkaistiin: 15.3.2024